The Leukemia & Lymphoma Society (LLS) is launching the first clinical trial for blood cancer patients at risk of death if infected with the COVID-19 virus.
The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences has announced a partnership to launch a global master clinical trial to develop new treatments for children with relapsed acute leukemia.